这是一篇来自已证抗体库的有关人类 p300的综述,是根据26篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合p300 抗体。
p300 同义词: KAT3B; RSTS2; p300; histone acetyltransferase p300; E1A-associated protein p300; E1A-binding protein, 300kD; histone butyryltransferase p300; histone crotonyltransferase p300; p300 HAT; protein propionyltransferase p300

圣克鲁斯生物技术
小鼠 单克隆(NM11)
  • 免疫印迹; 人类; 图 6d
圣克鲁斯生物技术 p300抗体(Santa Cruz Biotechnology, SC-32244)被用于被用于免疫印迹在人类样品上 (图 6d). J Exp Med (2018) ncbi
小鼠 单克隆(F-4)
  • 染色质免疫沉淀 ; 人类; 图 2h
圣克鲁斯生物技术 p300抗体(Santa Cruz, sc-48343X)被用于被用于染色质免疫沉淀 在人类样品上 (图 2h). Cancer Res (2018) ncbi
小鼠 单克隆(F-4)
  • proximity ligation assay; 小鼠; 图 3f
圣克鲁斯生物技术 p300抗体(Santa Cruz, sc-48343)被用于被用于proximity ligation assay在小鼠样品上 (图 3f). Nat Commun (2015) ncbi
小鼠 单克隆(F-4)
  • 染色质免疫沉淀 ; 大鼠; 图  6
  • 免疫印迹; 大鼠; 1:1000; 图 8
圣克鲁斯生物技术 p300抗体(Santa Cruz Biotechnology, sc-48343)被用于被用于染色质免疫沉淀 在大鼠样品上 (图  6) 和 被用于免疫印迹在大鼠样品上浓度为1:1000 (图 8). J Neurosci (2015) ncbi
小鼠 单克隆(NM11)
  • 染色质免疫沉淀 ; African green monkey
  • 免疫印迹; African green monkey
圣克鲁斯生物技术 p300抗体(Santa Cruz Biotechnology, sc-32244)被用于被用于染色质免疫沉淀 在African green monkey样品上 和 被用于免疫印迹在African green monkey样品上. J Biol Chem (2014) ncbi
小鼠 单克隆(F-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 p300抗体(Santa Cruz Biotechnology, sc-48343)被用于被用于免疫印迹在人类样品上. PLoS ONE (2012) ncbi
小鼠 单克隆(NM11)
  • 免疫组化-石蜡切片; 大鼠; 1:300
圣克鲁斯生物技术 p300抗体(Santa Cruz, sc-32244)被用于被用于免疫组化-石蜡切片在大鼠样品上浓度为1:300. Cell Mol Neurobiol (2013) ncbi
赛默飞世尔
小鼠 单克隆(RW105)
  • 染色质免疫沉淀 ; 人类; 图 5e
赛默飞世尔 p300抗体(Thermo Fisher, MA1-16622)被用于被用于染色质免疫沉淀 在人类样品上 (图 5e). Mol Immunol (2017) ncbi
小鼠 单克隆
  • 免疫沉淀; 人类; 2 ug
赛默飞世尔 p300抗体(life tech, 730044)被用于被用于免疫沉淀在人类样品上浓度为2 ug. Nat Methods (2015) ncbi
小鼠 单克隆(2033)
  • 免疫沉淀; 人类; 2 ug
赛默飞世尔 p300抗体(life tech, 730005)被用于被用于免疫沉淀在人类样品上浓度为2 ug. Nat Methods (2015) ncbi
兔 多克隆
  • 染色质免疫沉淀 ; 人类
赛默飞世尔 p300抗体(Thermo Scientific, PA1-848)被用于被用于染色质免疫沉淀 在人类样品上. J Biol Chem (2015) ncbi
小鼠 单克隆(NM-11)
  • 流式细胞仪; 小鼠; 图 5
  • 免疫细胞化学; 小鼠; 图 5
赛默飞世尔 p300抗体(生活技术, 33-7600)被用于被用于流式细胞仪在小鼠样品上 (图 5) 和 被用于免疫细胞化学在小鼠样品上 (图 5). Stem Cell Reports (2014) ncbi
小鼠 单克隆(RW105)
  • 免疫印迹; 人类
赛默飞世尔 p300抗体(Pierce Biotechnology, MA1-16622)被用于被用于免疫印迹在人类样品上. J Biol Chem (2014) ncbi
小鼠 单克隆(NM-11)
  • 免疫印迹; African green monkey; 图 s4
赛默飞世尔 p300抗体(Zymed, 33-7600)被用于被用于免疫印迹在African green monkey样品上 (图 s4). Nucleic Acids Res (2010) ncbi
小鼠 单克隆(NM-11)
  • 免疫印迹; 人类
赛默飞世尔 p300抗体(Zymed, 33-7600)被用于被用于免疫印迹在人类样品上. J Biol Chem (2007) ncbi
艾博抗(上海)贸易有限公司
小鼠 单克隆(3G230 / NM-11)
  • ChIP-Seq; 人类; 图 4g
艾博抗(上海)贸易有限公司 p300抗体(Abcam, ab14984)被用于被用于ChIP-Seq在人类样品上 (图 4g). Nat Commun (2017) ncbi
小鼠 单克隆(3G230 / NM-11)
  • 染色质免疫沉淀 ; 人类; 图 5g
艾博抗(上海)贸易有限公司 p300抗体(Abcam, ab14984)被用于被用于染色质免疫沉淀 在人类样品上 (图 5g). PLoS Genet (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 1
艾博抗(上海)贸易有限公司 p300抗体(Abcam, ab10485)被用于被用于免疫印迹在人类样品上 (图 1). Cancer Prev Res (Phila) (2015) ncbi
小鼠 单克隆(3G230 / NM-11)
  • 染色质免疫沉淀 ; 人类
艾博抗(上海)贸易有限公司 p300抗体(Abcam, ab-14984)被用于被用于染色质免疫沉淀 在人类样品上. Nucleic Acids Res (2014) ncbi
小鼠 单克隆
  • 免疫组化; 人类; 1:1500-1:3000; 图 2, 3
艾博抗(上海)贸易有限公司 p300抗体(Abcam, ab54984)被用于被用于免疫组化在人类样品上浓度为1:1500-1:3000 (图 2, 3). Cell Rep (2014) ncbi
小鼠 单克隆(3G230 / NM-11)
  • 染色质免疫沉淀 ; 人类
艾博抗(上海)贸易有限公司 p300抗体(Abcam, ab14984)被用于被用于染色质免疫沉淀 在人类样品上. BMC Cancer (2013) ncbi
Bethyl
兔 多克隆
  • ChIP-Seq; 人类; 图 s6
Bethyl p300抗体(Bethyl Laboratories, A300-358A)被用于被用于ChIP-Seq在人类样品上 (图 s6). Cell (2018) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 s4
Bethyl p300抗体(Bethyl, A300-358A)被用于被用于免疫印迹在人类样品上 (图 s4). Cancer Res (2018) ncbi
兔 多克隆
  • ChIP-Seq; 人类; 图 5a
Bethyl p300抗体(Bethyl, A300-358A)被用于被用于ChIP-Seq在人类样品上 (图 5a). Exp Hematol (2017) ncbi
兔 多克隆
  • ChIP-Seq; 人类; 图 2
Bethyl p300抗体(Bethyl Laboratories, A300-358A)被用于被用于ChIP-Seq在人类样品上 (图 2). Genes Dev (2015) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 人类; 图 1,2
Bethyl p300抗体(Bethyl, IHC-00028)被用于被用于免疫组化-石蜡切片在人类样品上 (图 1,2). Biophys J (2015) ncbi
Novus Biologicals
兔 多克隆
  • 免疫沉淀; 人类; 图 12
  • 免疫印迹; 人类; 图 12
Novus Biologicals p300抗体(Novus Biologicals, NB500-161)被用于被用于免疫沉淀在人类样品上 (图 12) 和 被用于免疫印迹在人类样品上 (图 12). Oncotarget (2016) ncbi
安迪生物R&D
山羊 多克隆
  • 免疫印迹; 人类; 图 5i
安迪生物R&D p300抗体(R&D Systems, AF3789)被用于被用于免疫印迹在人类样品上 (图 5i). Cell (2018) ncbi
文章列表
  1. Pulikkan J, Hegde M, Ahmad H, Belaghzal H, Illendula A, Yu J, et al. CBFβ-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia. Cell. 2018;174:172-186.e21 pubmed 出版商
  2. Su S, Chen J, Yao H, Liu J, Yu S, Lao L, et al. CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness. Cell. 2018;172:841-856.e16 pubmed 出版商
  3. Xiao X, Fan Y, Li J, Zhang X, Lou X, Dou Y, et al. Guidance of super-enhancers in regulation of IL-9 induction and airway inflammation. J Exp Med. 2018;215:559-574 pubmed 出版商
  4. Wu Y, Zhang Z, Cenciarini M, Proietti C, Amasino M, Hong T, et al. Tamoxifen Resistance in Breast Cancer Is Regulated by the EZH2-ERα-GREB1 Transcriptional Axis. Cancer Res. 2018;78:671-684 pubmed 出版商
  5. Monteagudo S, Cornelis F, Aznar López C, Yibmantasiri P, Guns L, Carmeliet P, et al. DOT1L safeguards cartilage homeostasis and protects against osteoarthritis. Nat Commun. 2017;8:15889 pubmed 出版商
  6. Lin Y, Lin Y, Huang M, Kuo P, Wu C, Lee M, et al. Tumor necrosis factor-alpha inhibitors suppress CCL2 chemokine in monocytes via epigenetic modification. Mol Immunol. 2017;83:82-91 pubmed 出版商
  7. Godfrey L, Kerry J, Thorne R, Repapi E, Davies J, Tapia M, et al. MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation. Exp Hematol. 2017;47:64-75 pubmed 出版商
  8. Luo W, Chen I, Chen Y, Alkam D, Wang Y, Semenza G. PRDX2 and PRDX4 are negative regulators of hypoxia-inducible factors under conditions of prolonged hypoxia. Oncotarget. 2016;7:6379-97 pubmed 出版商
  9. Stein C, Bardet A, Roma G, Bergling S, Clay I, Ruchti A, et al. YAP1 Exerts Its Transcriptional Control via TEAD-Mediated Activation of Enhancers. PLoS Genet. 2015;11:e1005465 pubmed 出版商
  10. Alekseyenko A, Walsh E, Wang X, Grayson A, Hsi P, Kharchenko P, et al. The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains. Genes Dev. 2015;29:1507-23 pubmed 出版商
  11. McLane J, Ligon L. Palladin mediates stiffness-induced fibroblast activation in the tumor microenvironment. Biophys J. 2015;109:249-64 pubmed 出版商
  12. Yoon J, Sudo K, Kuroda M, Kato M, Lee I, Han J, et al. Phosphorylation status determines the opposing functions of Smad2/Smad3 as STAT3 cofactors in TH17 differentiation. Nat Commun. 2015;6:7600 pubmed 出版商
  13. Marcon E, Jain H, Bhattacharya A, Guo H, Phanse S, Pu S, et al. Assessment of a method to characterize antibody selectivity and specificity for use in immunoprecipitation. Nat Methods. 2015;12:725-31 pubmed 出版商
  14. Wang S, Awad K, Elinoff J, Dougherty E, Ferreyra G, Wang J, et al. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY. J Biol Chem. 2015;290:19544-57 pubmed 出版商
  15. Formisano L, Guida N, Valsecchi V, Cantile M, Cuomo O, Vinciguerra A, et al. Sp3/REST/HDAC1/HDAC2 Complex Represses and Sp1/HIF-1/p300 Complex Activates ncx1 Gene Transcription, in Brain Ischemia and in Ischemic Brain Preconditioning, by Epigenetic Mechanism. J Neurosci. 2015;35:7332-48 pubmed 出版商
  16. Shukla S, Khan S, Kumar S, Sinha S, Farhan M, Bora H, et al. Cucurbitacin B Alters the Expression of Tumor-Related Genes by Epigenetic Modifications in NSCLC and Inhibits NNK-Induced Lung Tumorigenesis. Cancer Prev Res (Phila). 2015;8:552-62 pubmed 出版商
  17. Moquet Torcy G, Tolza C, Piechaczyk M, Jariel Encontre I. Transcriptional complexity and roles of Fra-1/AP-1 at the uPA/Plau locus in aggressive breast cancer. Nucleic Acids Res. 2014;42:11011-24 pubmed 出版商
  18. Onishi K, Tonge P, Nagy A, Zandstra P. Local BMP-SMAD1 signaling increases LIF receptor-dependent STAT3 responsiveness and primed-to-naive mouse pluripotent stem cell conversion frequency. Stem Cell Reports. 2014;3:156-68 pubmed 出版商
  19. Nordentoft I, Lamy P, Birkenkamp Demtroder K, Shumansky K, Vang S, Hornshøj H, et al. Mutational context and diverse clonal development in early and late bladder cancer. Cell Rep. 2014;7:1649-1663 pubmed 出版商
  20. Mackeh R, Lorin S, Ratier A, Mejdoubi Charef N, Baillet A, Bruneel A, et al. Reactive oxygen species, AMP-activated protein kinase, and the transcription cofactor p300 regulate ?-tubulin acetyltransferase-1 (?TAT-1/MEC-17)-dependent microtubule hyperacetylation during cell stress. J Biol Chem. 2014;289:11816-28 pubmed 出版商
  21. Wehmeyer L, Du Toit A, Lang D, Hapgood J. Lipid raft- and protein kinase C-mediated synergism between glucocorticoid- and gonadotropin-releasing hormone signaling results in decreased cell proliferation. J Biol Chem. 2014;289:10235-51 pubmed 出版商
  22. Wagner M, Koslowski M, Paret C, Schmidt M, Tureci O, Sahin U. NCOA3 is a selective co-activator of estrogen receptor ?-mediated transactivation of PLAC1 in MCF-7 breast cancer cells. BMC Cancer. 2013;13:570 pubmed 出版商
  23. Ogiwara H, Kohno T. CBP and p300 histone acetyltransferases contribute to homologous recombination by transcriptionally activating the BRCA1 and RAD51 genes. PLoS ONE. 2012;7:e52810 pubmed 出版商
  24. Zhu X, Huang C, Li Q, Guo Q, Wang Y, He X, et al. Temporal distribution of p300/CBP immunoreactivity in the adult rat spinal dorsal horn following chronic constriction injury (CCI). Cell Mol Neurobiol. 2013;33:197-204 pubmed 出版商
  25. Molvaersmyr A, Saether T, Gilfillan S, Lorenzo P, Kvaløy H, Matre V, et al. A SUMO-regulated activation function controls synergy of c-Myb through a repressor-activator switch leading to differential p300 recruitment. Nucleic Acids Res. 2010;38:4970-84 pubmed 出版商
  26. Saether T, Berge T, Ledsaak M, Matre V, Alm Kristiansen A, Dahle O, et al. The chromatin remodeling factor Mi-2alpha acts as a novel co-activator for human c-Myb. J Biol Chem. 2007;282:13994-4005 pubmed